United States of America v. Healthcare Associates of Texas LLC

District Court, N.D. Texas·Decided October 28, 2024·No. 3:19-cv-02486·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION

UNITED STATES OF AMERICA, § ex rel. CHERYL TAYLOR, § § Plaintiff, § § v. § Civil Action No. 3:19-CV-02486-N § HEALTHCARE ASSOCIATES OF § TEXAS, LLC, et al., § § Defendants. §

MEMORANDUM OPINION AND ORDER

This Order addresses Defendants’ (collectively, “HCAT”) motions to strike rebuttal expert reports of Heather Moffitt (“Moffitt Mot.”) [496] and Mark Anderson, Dr. Sunil Lalla, Melissa Scott, Nicholas Ross, and Dr. Joseph Krock (“Anderson Mot.”) [497]. Because the Court finds that each of these expert reports contain proper rebuttal opinions, the Court denies both motions. I. ORIGINS OF THE DISPUTE This case deals with claims under the False Claims Act, 31 U.S.C. § 3729, et seq. Taylor alleges that she observed HCAT employ fraudulent Medicare billing practices. The Court has discussed Taylor’s factual allegations at some length, see, e.g., United States ex rel. Taylor v. Healthcare Assocs. of Tex., LLC, 2023 WL 3294141, at *1 (N.D. Tex. 2023), and the Court will not recount them in great depth here. Defendants now move to strike six of Taylor’s expert rebuttal reports on the grounds that they contain improper rebuttal testimony. II. LEGAL STANDARD Federal Rule of Civil Procedure 26(a)(2)(D)(ii) allows for the designation of a rebuttal expert witness “solely to contradict or rebut evidence on the same subject matter

identified by another party under Rule 26(a)(2)(B) or (C).” “The scope of rebuttal testimony is ordinarily a matter to be left to the sound discretion of the trial judge.” Tramonte v. Fibreboard Corp., 947 F.2d 762, 764 (5th Cir. 1991). “A ‘rebuttal’ report explains, repels, counteracts, or disproves evidence of the adverse party’s initial report.” CEATS, Inc. v. TicketNetwork, Inc., 2018 WL 453732, at *3 (E.D. Tex. 2018). “Rebuttal

is a term of art, denoting evidence introduced by a plaintiff to meet new facts brought out in his opponent’s case in chief.” GWTP Invs., L.P. v. SES Americom, Inc., 2007 WL 7630459, at *9 (N.D. Tex. 2007). When addressing whether an expert witness is a rebuttal witness, district courts often ask three questions: First, what evidence does the rebuttal expert purport to contradict or rebut? Second, is the evidence disclosed as rebuttal evidence on the same subject matter as that identified by another party in its Rule 26(a)(2)(B) disclosure? Third, is the evidence disclosed as rebuttal evidence intended solely to contradict or rebut that evidence?

Poly-Am., Inc. v. Serrot Int’l, Inc., 2002 WL 1996561, at *15 (N.D. Tex. 2002); see also, e.g., United States ex rel. Simms v. Austin Radiological Ass’n, 2014 WL 2515696, at *4 (W.D. Tex. 2014) (citing Poly-Am., Inc., 2002 WL 1996561, at *15); Wireless Agents, L.L.C. v. Sony Ericsson Mobile Commc'ns AB, 2006 WL 5127278, at *2 (N.D. Tex. 2006) (same).1 Impermissible rebuttal testimony should be excluded. See Kanida v. Gulf Coast Med. Pers. LP, 363 F.3d 568, 583 (5th Cir. 2004). III. THE COURT DENIES THE MOTION TO STRIKE MOFFITT’S REBUTTAL REPORT

Taylor retained Heather Moffitt to provide rebuttal opinions about effective billing dates under 42 C.F.R. § 424.521 and about Provider Transaction Access Number (“PTAN”) assignments. Moffitt Report at Rel.’s Appx. 223–24 [559]. Moffitt states that her report responds to the opinions of two of HCAT’s experts — Shay and Gosfield. Id. at 223. HCAT argues that Moffitt’s testimony addresses issues that have been present from

the beginning of the case, and therefore do not constitute proper rebuttal testimony. See Moffitt Mot. 6–12. It also argues that her disclosure was faulty (by not including documents she relied on) and that she should be prevented from testifying on credentialling subjects because Taylor previously withdrew a different expert on the same subject. See

1 HCAT asserts that the applicable standard for determining proper rebuttal testimony is whether it responds to “expected and anticipated” testimony from the opposing party’s case in chief. Moffitt Mot. 5 (quoting Morgan v. Com. Union Assurance Cos., 606 F.2d 554, 556 (5th Cir. 1979)). However, HCAT’s reliance on this quote from Morgan is misguided. In Morgan, the court addressed a situation where the defendant withheld the identity of a witness until trial. 606 F.2d at 555. To attempt to avoid exclusion, the defendant tried to characterize the witness as a “rebuttal witness” because the trial court’s pretrial order did not require disclosure of rebuttal witnesses. Id. The Fifth Circuit affirmed exclusion of the witness, noting that “a defense witness whose purpose is to contradict an expected and anticipated portion of the plaintiff’s case in chief can never be considered a ‘rebuttal witness’” because that witness should appear as part of the defense’s case in chief. See id. at 556. In this case, there is no question as to whether the challenged experts are rebuttal witnesses — they are. The question here is one of scope. Specifically, whether the testimony of the rebuttal witnesses goes to issues raised by the opposing party’s experts. On that question, this “expected and anticipated” language is not controlling. id. Because the Court finds Moffitt’s opinions are proper rebuttals of Gosfield and Shay’s opinions, the Court denies the motion to strike her report. Moffitt’s opinion on effective billing dates properly rebuts Shay and Gosfield’s

opinions on the subject. Shay and Gosfield state that 42 C.F.R. § 424.521 generally permits providers to bill Medicare for services rendered up to thirty days before their effective billing date, as long as Medicare ultimately approves their enrollment. Shay Report at Rel.’s Appx. 685; Gosfield Report at Rel.’s Appx. 47. Shay then relies on 42 C.F.R. § 424.521 to conclude that HCAT’s billing for services rendered before the Medicare

Administrative Contractor (“MAC”) received the provider’s enrollment application was reasonable. Shay Report at Rel.’s Appx. 685–86. In response, Moffitt opines that the effective dates a MAC gives to a practice incorporate this thirty-day period, meaning that HCAT should not have been billing for thirty days before that date. Moffitt Report at Rel.’s Appx. 225. This opinion on retrospective billing directly contradicts Shay and Gosfield’s

opinions on the same topic. Accordingly, it is proper rebuttal testimony. Moffitt’s PTAN opinions are likewise proper rebuttal testimony. On this subject, Shay opines that HCAT’s practice of assigning practitioners to only one PTAN instead of each PTAN associated with HCAT was consistent with Medicare regulations. Shay Report at Rel.’s Appx. 699. In response, Moffitt states, “if a medical practice submits a claim for

a provider who is not associated with the correct PTAN, a MAC will not pay that claim.” Moffitt Report at Rel.’s Appx. 229. In essence, Moffitt argues that HCAT’s practice here was actually inconsistent with Medicare requirements. This is a direct contradiction of Shay’s arguments about PTANs and is therefore proper rebuttal testimony.

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America v. Healthcare Associates of Texas LLC, (N.D. Tex. 2024).

United States of America v. Healthcare Associates of Texas LLC (United States of America v. Healthcare Associates of Texas LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related